Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of GKT137831 in Patients with Idiopathic Pulmonary Fibrosis
Conditions
Interventions
Placebo Oral Tablet
GKT137831
Locations
4
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Tulane University Medical Center
New Orleans, Louisiana, United States
University of Michigan Medical Center
Ann Arbor, Michigan, United States
Temple University Medical Center
Philadelphia, Pennsylvania, United States
Start Date
September 7, 2020
Primary Completion Date
November 30, 2024
Completion Date
November 30, 2024
Last Updated
December 10, 2024
NCT06238622
NCT07299695
NCT07466420
NCT06241560
NCT05674994
NCT07407543
Lead Sponsor
University of Alabama at Birmingham
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions